RE:RE:RE:RE:RE:RE:RE:RE:RE:take-out , soon at these prices A few points regarding your comparisons. Certainly as a matter of scale Tesla is multiple times PLI's size, but that doesn't really change the underlying dynamic, they are both losing money. I certainly agree with less than a years worth of cash to draw on, it's a heavy drag on the share price. I've commented on this previously, questioning some of the management's decisions with regards to implimentation and timing. I would question your characterization of PLI's Reputation of quality as 'Not yet'. I would suggest GSK would disagree with you. Remember, it was GSK, when PLI was running of fumes and in real danger of folding, that still went to PLI based on the quality their platform technology provided. As a service provider to other pharmaceutical companies, I don't think PLI is held in other than the highest regards. I presume your reference was more to PLI as the burgeoning pharma company?
Thanks for taking the time to provide a thoughtful rebuttal.To close the conversation, take your comparibles for PLI and Tesla and overlay Tesla against GM and Telsa doesn't quite look the shiny jewel the market indicates it is. GM would best them on most every count, but Mr. market views Tesla as something more than what it is, a car manufacturing company. Even if it could meet its goal of a 500,000 unit output, it would only represent 5% of GM's present capacity. How easily could they scale to 1,000,000 units? 210,000 units sold and it's worth more by market cap than GM. It's the obsurdtity of the valuation that I used to illustrate my point of not underestimating where the market cap could go on PLI.
Like yourself, I'd be very happy with $9.00 and I'm comforted by the fact that in the eyes of more than a handful of analysts, it's a distinct possibility.
Good luck,
Felco